国产西罗莫司洗脱支架与紫杉醇洗脱支架临床效果比较研究Compare homemade sirolimus-eluting stent to paclitaxel-eluting stent with clinical effect
乔树宾,侯青,徐波,陈珏,刘海波,杨跃进,吴永健,袁晋青,吴元,戴军,尤士杰,张沛,高展,马卫华,窦克非,邱洪,慕朝伟,陈纪林,高润霖
摘要(Abstract)：
目的比较国产西罗莫司洗脱支架(FBS)和进口紫杉醇洗脱支架(PES)治疗冠状动脉狭窄的效果。方法选择阜外心血管病医院2004年4月至2005年8月连续接受国产西罗莫司洗脱支架或紫杉醇洗脱支架治疗,并且进行冠状动脉造影随访的228例冠心病患者。排除支架置入失败、位置不理想者。所有的患者术后均接受阿司匹林300mg/d、氯吡格雷75mg/d等规范药物治疗。患者在支架术后6个月后接受冠状动脉造影随访。结果共228例患者(198名男性,30名女性)314个靶病变接受治疗并完成造影随访。其中C型病变占总数的40.1%,平均术前参考血管直径2.80±0.47mm。平均每个病变支架长度25.90±14.54mm。228例患者中118例置入紫杉醇洗脱支架,100例置入西罗莫司洗脱支架。两组在患者基本条件方面,国产西罗莫司洗脱支架组患者年龄大于紫杉醇洗脱支架组,紫杉醇洗脱支架组有更多的2型糖尿患者;在病变基本条件方面,国产西罗莫司洗脱支架组病变更多偏心性病变,其他没有差别。6个月后随访结果国产西罗莫司洗脱支架组的支架再狭窄率明显低于紫杉醇洗脱支架组(5.3%比21.9%,P<0.001)。国产西罗莫司洗脱支架组的靶病变血管重建率(TLR)明显低于紫杉醇洗脱支架组(3.8%比13.1%,P<0.001)。国产西罗莫司洗脱支架组支架内晚期腔径丢失明显小于紫杉醇洗脱支架组(0.18±0.41mm比0.58±0.69mm,P<0.001)。结论国产西罗莫司涂层支架用于临床实践有良好的疗效。
关键词(KeyWords)： 支架;冠状动脉再狭窄;冠状血管造影术;冠状动脉疾病
基金项目(Foundation): 科技部社会公益基金(2002DIB40092)
作者(Author): 乔树宾,侯青,徐波,陈珏,刘海波,杨跃进,吴永健,袁晋青,吴元,戴军,尤士杰,张沛,高展,马卫华,窦克非,邱洪,慕朝伟,陈纪林,高润霖
参考文献(References)：
- [1]倪钧,沈卫峰,张建盛,等.Firebird药物洗脱支架治疗冠状动脉原发病变.介入放射学杂志,2004,13:396-398.
- [2]Grube E,Sillber S,Hauptmann KE,et al.,TAXUS I:six-and twelve-munth results from a randomized,double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.Circulation,2003,107:38-42.
- [3]Colombo A,Drzewiecki J,Hauptmann KE,et al.Randomized study to assess the effectiveness of slow-and moderate-release polymerbased paclitaxel-eluting stents for coronary artery lesions.Circulation,2003,107:788-794.
- [4]Stone GW,Ellis SG,Cox DA,et al.One-year clinical results with the slow-release,polymer-based,paclitaxel-eluting TAXUS stent.The TAXUS-IV trial.Circulation,2004,109:1942-1947.
- [5]Mosees JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versus standard stents in patents with stenosis in a native cotonary artery.N Engl J Med,2003,349:1315-1323.
- [6]Ellis SG,Popma JJ,Lasala JM,et al.Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation::analysis from the TAXUS-IV trial.JACC,2005,45:1193-1199.
- [7]Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med,2002,346:1773-1780.
- [8]Leon MB,Moses JW,Popma JJ,et al.A multicenter randomized clinical study of the Sirolimus-eluting stent in native coronary lesions:angiographic results.Circulation,2002,106:II-393.
- [9]Jeffrey JP,Martin BL,Jeffrey WM,et al.Quantitative assessment of angiographic restenosis after sirolimus-eluting stent imp;antation in native coronary arteries.Circulation,2004,110:3773-3780.